Análisis opcionales del producto
Con tu permiso, usamos análisis limitados y respetuosos con la privacidad para entender qué recorridos de investigación funcionan. No usamos rastreadores publicitarios ni grabación de sesiones. Puedes cambiar esta opción en Preferencias. Lee la Política de privacidad.
Healthpeak Properties, Inc.'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $14.4B | |
|---|---|---|
| Revenue (ttm) | 2.9B | |
| Net income (ttm) | 242.7M | |
| EPS (ttm) | $0.34 | |
| Shares out | 702.5M | |
| P/E (trailing) | 53.8x | |
| P/E (forward) | 169.5x | |
| Dividend | $1.22 (6.61%) | |
| Volume | 3,305,847 | |
| Beta | 0.99 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $471.3M | $494.9M | $527.4M | $568.5M | $604.0M | +6.4% |
| Gross profit | $1.12B | $1.20B | $1.28B | $1.63B | $634.5M | -13.3% |
| Operating income | $286.3M | $680.1M | $515.3M | $553.6M | $415.5M | +9.8% |
| Net income | $505.5M | $500.4M | $306.0M | $243.1M | $71.3M | -38.7% |
| EPS (diluted) | $0.93 | $0.92 | $0.56 | $0.36 | $0.10 | -42.7% |
| EBITDA | $970.6M | $1.39B | $1.27B | $1.61B | $1.47B | +11.0% |
| R&D | $0 | $0 | $0 | — | — | +41.4% |
| SG&A | $98.3M | $131.0M | $95.1M | $97.2M | $90.4M | -2.1% |
Recent company headlines from major financial publishers.
Defensive outpatient medical cash flows deliver steady collections, balancing lab leasing drag and debt service to yield $29.98 from $20.33.
Post-merger integration accelerates synergies, outpatient rent escalations exceed historical norms, and life science leasing spreads rebound, supporting $40.86.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.4% | $78.0 | $78.3 | $78.8 | $79.4 | $80.2 |
| 7.4% | $42.6 | $42.8 | $43.1 | $43.5 | $43.9 |
| 8.4% | $29.6 | $29.8 | $30.0 | $30.2 | $30.5 |
| 9.4% | $22.8 | $23.0 | $23.1 | $23.3 | $23.4 |
| 10.4% | $18.6 | $18.7 | $18.8 | $18.9 | $19.1 |
Upcoming earnings date and setup when available.
La calificación que llevaba la edición de análisis publicada cada mes. Una calificación compara el precio en la fecha del análisis con el valor razonable; no es un registro de si la valoración acertó.
| Año | ene | feb | mar | abr | may | jun | jul | ago | sept | oct | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
